Health Care: Drugs

IDEXX Laboratories Inc (IDXX: NASDAQ)

$118.17 0.15 | 0.13%
12/08/16 - 12:06 PM ET
Company Income Statement
Dec 2015 Dec 2014 Dec 2013 Dec 2012
Sales 1.60B 1.49B 1.38B 1.29B
Cost of Sales 641.23M 610.80M 566.34M 541.78M
Gross Operating Profit 960.66M 875.00M 810.71M 751.56M
Selling, General, and Administrative Expenses 482.46M 457.60M 401.35M 354.57M
Research & Development 99.68M 98.26M 88.00M 82.01M
Operating Income before D & A (EBITDA) 378.51M 319.14M 321.36M 314.97M
Depreciation & Amortization 70.39M 58.89M 54.60M 52.41M
Interest Income 2.47M 1.73M 1.89M 1.90M
Other Income - Net 0.00 0.00 0.00 0.00
Special Income / Charges -8.21M 0.00 0.00 0.00
Total Income Before Interest Expenses (EBIT) 302.38M 261.98M 268.65M 264.46M
Interest Expense 29.24M 15.43M 5.39M 3.85M
Pre-Tax Income 273.14M 246.56M 263.26M 260.62M
Income Taxes 81.01M 64.60M 75.47M 82.33M
Minority Interest 57.00K 45.00K -6.00K 20.00K
Net Income From Continuing Operations 192.13M 181.95M 187.79M 178.29M
Net Income From Discontinued Operations 0.00 0.00 0.00 0.00
Net Income From Total Operations 192.13M 181.95M 187.79M 178.29M
Extraordinary Income/Losses 0.00 0.00 0.00 0.00
Income From Cum. Effect of Acct. Change 0.00 0.00 0.00 0.00
Income From Tax Loss Carryforward 0.00 0.00 0.00 0.00
Other Gains / Losses 0.00 0.00 0.00 0.00
Total Net Income 192.08M 181.91M 187.80M 178.27M
Normalized Income
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
200.35M 181.95M 187.79M 178.29M
Preferred Dividends
Net Income Available To Common 192.13M 181.95M 187.79M 178.29M
Basic EPS from Continuing Ops. 2.07 1.82 1.77 1.62
Basic EPS from Discontinued Ops. 0.00 0.00 0.00 0.00
Basic EPS from Total Operations 2.07 1.82 1.77 1.62
Basic EPS from Extraordinary Inc. 0.00 0.00 0.00 0.00
Basic EPS from Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
Basic EPS from Tax Loss Carryf'd. 0.00 0.00 0.00 0.00
Basic EPS from Other Gains (Losses) 0.00 0.00 0.00 0.00
Basic EPS, Total 2.07 1.82 1.77 1.62
Basic Normalized Net Income/Share 2.16 1.82 1.77 1.62
EPS fr Continuing Ops. 2.05 1.79 1.74 1.59
EPS fr Discontinued Ops 0.00 0.00 0.00 0.00
EPS fr Total Ops. 2.05 1.79 1.74 1.59
EPS fr Extraord. Inc. 0.00 0.00 0.00 0.00
EPS fr Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
EPS fr Tax Loss Carfd. 0.00 0.00 0.00 0.00
EPS fr Other Gains (L) 0.00 0.00 0.00 0.00
EPS, Total 2.05 1.79 1.74 1.59
Diluted Normalized Net Inc/Shr
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
2.14 1.79 1.74 1.59
Dividends Paid per Share 0.00 0.00 0.00 0.00

Portfolios with IDXX

Latest IDXX Headlines from TheStreet

More Financial News for IDXX

Press Releases for IDXX

See All Press Releases
brokerage partners
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter